Default on bank loans exceeds 30 days across two lenders

Loan NpaCredit & Debt View source PDF Explain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹27.75

prior close

₹28.79

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%+0.5% vs market

Pharmaceuticals peers, median of 175sector+0.0%+0.9% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.4

15m

-0.8

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+0.4+0.5+0.0+0.9

Next day

-2.7-0.2-2.5-0.5-2.2

-3.2+0.3-3.5-0.1-3.0

-0.2+0.6-0.7-0.2+0.0

+9.7+0.8+8.9-0.4+10.1

+17.8+0.4+17.5-0.7+18.6

+15.6+0.7+14.8-0.6+16.2

15d

+5.3+2.0+3.3+1.6+3.7

+23.2+0.7+22.5+1.7+21.6

+9.9-3.4+13.3-4.2+14.1

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 175Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mangalam Drugs has defaulted on cash credit accounts with Bank of Maharashtra (Rs. 951.19 lakhs overdue since 17 Oct 2025) and Bank of Baroda (Rs. 606.08 lakhs overdue since 20 Oct 2025), totalling about Rs. 15.57 crores. Default has continued beyond 30 days, triggering SEBI disclosure rules. Management says it is arranging to pay the overdue amounts soon.

Likely market impact

Negative for shareholders. Loan default may raise borrowing costs and concerns about the company's financial health. Watch for possible stock price pressure.